Botulinum Journal

Aims & Scope

Botulinum neurotoxins are a unique group of proteins, with extreme biological activities in areas such as toxins, therapeutics and cosmetics.

Clostridium botulinum has become a source of bioterror and beauty, both being pursued simultaneously for scientific development to counter the former while promoting the latter.

TBJ provides an international forum and authoritative source of information encompassing varied fields, including microbiology, biochemistry, biophysics, biotechnology, proteomics, genomics, pharmacology, toxicology, drug development related to different forms/types of botulinum neurotoxins, and also Clostridium botulinum.

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Neuroscience and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• How do the Botulinum Neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action

  Citation: 88

  Authors: Bernard, Michel R., Jordi

• Biochemical, functional and potency characteristics of type A botulinum toxin in clinical use

  Citation: 45

  Authors: Naveed, Roderic, Andy

• Utility of Botulinum Toxin ELISA A, B, E, F kits for clinical laboratory investigations of human botulism

  Citation: 24

  Authors: Susan E., Carolina, Brian H., Janet K., Lavin A.

• Botulism mortality in the USA, 1975-2009

  Citation: 24

  Authors: Kelly A., Barbara E., John, Ryan P.

• Stability of botulinum neurotoxin type A, devoid of complexing proteins

  Citation: 14

  Authors: Swen, Gerd J., Klaus

• Expression, purification and comparative characterisation of enzymatically deactivated recombinant botulinum neurotoxin type A

  Citation: 12

  Authors: Weiping, Paul, Stephen, Tzuu Wang, Shuowei, Thuan, Roshan, Yu, Kruti, Bal Ram

• Enhanced sensitivity to Botulinum type A neurotoxin of human neuroblastoma SH-SY5Y cells after differentiation into mature neuronal cells

  Citation: 11

  Authors: C. Rasetti, C.B., R. Preneta, R.A., D.

• Evaluation of llama anti-botulinum toxin Heavy chain Antibody

  Citation: 9

  Authors: George P., Yakelin A. Ortiz, Andrew, Jill, Jason, BaoHan, Ellen R.

• Comparison of Clostridium botulinum genomes shows the absence of cold shock protein coding genes in type E neurotoxin producing strains

  Citation: 8

  Authors: Henna, Kaisa, Panu, Pia, Petri, Lars, Miia, Hannu

• Reflections on the care of a patient severely poisoned by 'rogue' botulinum toxin and rendered paralysed for a protracted hospital stay

  Citation: 8

  Authors: Steven M.